<!--
MVT in Silico, a drug development company.
http://mvtsilico.com
Copyright: MVT in Silico, 2025.
-->
<html>
<head>
 <meta charset="UTF-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Privacy Policies.</title>
<link rel="stylesheet" href="styles.css">
</head>
<body>
<!--- -- Navigation menu from: https://codepen.io/erikterwan/pen/EVzeRP -->

<!--- Main content -->
<main>
<h5>MVT in Silico’s privacy policies.</h5>
<p>
MVT in Silico Corp (the Company) is a responsible company. The only way this website collects your 
information is when you give it to us voluntarily, say using the email address above. We do not share, 
disclose, sell, or trade your information with anyone. As a company, we may add you to our informative 
mailing lists used for monthly newsletters and occasional announcements. In case we provide links to 
other websites, we are not responsible for their content and policies. This website attempts to minimize 
use of web cache and cookies and minimizes your (and our) internet related risks. We do not use web analytics. 
We do not use social media plugins. We do not use third party advertising. You may withdraw your explicit 
consent by sending email to: sumus@mvtinsilico.ca .<br>

MVTIS embraces the Canadian federal Personal Information Protection and Electronic Documents Act (PIPEDA 2009) 
and acknowledge the importance of national standards that are designed to protect the personal information that we collect. 
As such, the company's CEO is responsible for all personal information that is held, received, and deployed. 
Personal information that is not otherwise required is destroyed and erased from our paper and electronic records.<br>
 
The protection of your privacy is very important to the Company and we are committed to safeguarding your data and the 
information of the individuals and organizations with whom we interact including visitors to our websites or recipients 
of marketing emails. This Privacy Statement is issued by the Company on behalf of itself and its domestic and international 
subsidiaries and affiliates (“the Company”, “we”, “us”, or “our”) and sets out how we will treat your personal information.<br>
 
​We are a drug development organization focused on progressing innovations from discovery to Phase I R&D in partnership with 
leading pharmaceutical and biotechnology companies, academics, patient advocacy groups, venture capitalists and other 
industries which may use our services. We have a B2B model with nil direct interaction with patients and retail consumers. 
As such the information that we collect, hold, and process is confined to the normal operation of our business. We do not collect, 
hold, and process identity revealing personal information.<br>  

​We may amend or update this privacy statement from time to time to reflect changes in our practices with respect to the 
processing of personal information or changes to applicable law.<br>
 
​​We routinely create marketing materials that we use in our online and physical marketing and advertising. We ensure having 
your written consent prior to including images and content of you, materials that you own, and similar objects that belong 
to you.<br>
 
To protect our customers, clients, partners, providers, and all persons involved all our data is stored using sophisticated 
encryption, on secure computers owned by the company. We take responsibility for all data that we possess, curate, and deploy 
for our business purposes. All our email is password protected with multilevel security.<br>
 
In the course of our business operations, pursual of legitimate interests, internal administrative purposes, 
and in the fulfillment of our obligations (e.g., processing of purchase orders, deliveries, payments, use of services, 
response to your requests or the preparation of and response to quotation requests, or determining the establishment or 
terms of a contractual relationship) we will be required to use your information (e.g., your professional email address, 
your business phone number, your physical business address) as regards our business relationships. All such information is 
held securely by the Company using its devices, email services, and similar instruments. In the event when you or your 
representatives visit our premises, every individual’s personal and professional privacy will be ensured.<br>
 
Within the scope of our business relationship, you must provide those personal data that are necessary for the establishment, 
implementation and termination of a business relationship and for the fulfillment of the associated obligations, for which 
we are obliged to collect the data by law or are entitled to collect on the basis of a contract or on the basis of our 
legitimate interests. Without this data, we will generally not be able to contact you and/or enter into a business 
relationship with you. If you have provided us with data voluntarily, we will indicate this accordingly when collecting the 
data.<br>
 
We will retain your personal information for the period necessary to fulfill the purposes outlined in this privacy statement.<br>
 
All inquires related to our extended privacy policy can be directed to: sumus@mvtinsilico.ca .<br>
 
February 20, 2026.
</main>

</body>
</html>
